Cite
MLA Citation
Hui Liu et al.. “Idarubicin plus BuCy versus BuCy conditioning regimens for intermediate‐risk acute myeloid leukemia in first complete remission undergoing auto‐HSCT: An open‐label, multicenter, randomized phase 3 trial.” American journal of hematology, vol. 98, no. 3, 2023, pp. 408–412. http://access.bl.uk/ark:/81055/vdc_100177829630.0x00004d